What this Trial Is About

Researchers are evaluating the clinical outcomes of using indocyanine green fluorescence imaging during laparoscopic radical right hemicolectomy for treating right colon cancer (stages T1 to T4a, with lymph node involvement but no distant metastasis). The study compares this combined procedure to standard radical right hemicolectomy to see if adding the fluorescence imaging improves treatment results. Participants will undergo either a standard radical right hemicolectomy or the same surgery combined with indocyanine green fluorescence imaging lymphatic tracer dissection. This imaging technique helps visualize lymphatic structures during surgery for potentially better removal of affected tissue. The study is designed as a prospective, randomized, open, parallel-controlled trial to assess differences between the two approaches. During the study, participants will be monitored for disease-free survival over three years as the primary outcome. Researchers will collect data on clinical outcomes and surgical effectiveness. Patients and their families will be informed about the study and provide consent to participate, with follow-up evaluations conducted to assess the long-term results of the treatments.

Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer